Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF).
Matthew Meng Yang LeeKeith A GillisKatriona J M BrooksbankSarah Allwood-SpiersPauline Hall BarrientosKirsty WetherallGiles RoditiBashair AlHummianyColin BerryRoss T CampbellVictor ChongLiz CoyleKieran F DochertyJohn G DreisbachBernd KuehnCatherine LabinjohNinian N LangVera LennieKenneth MangionAlexander McConnachieClare L MurphyColin J PetrieJohn R PetrieKanishka SharmaSteven SourbronIain A SpeiritsJoyce ThompsonPaul I WelshRosemary WoodwardAnn WrightAleksandra RadjenovicJohn Joseph Valentine McMurrayPardeep S JhundMark Colquhoun PetrieNaveed SattarPatrick B MarkPublished in: Circulation (2022)